Travere Therapeutics, Inc.
Overview
Travere Therapeutics, Inc., formerly known as Retrophin, Inc., is a biopharmaceutical company focused on developing treatments for rare diseases. The company strives to address unmet medical needs and improve patient care in various therapeutic areas.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Travere Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.